Unknown

Dataset Information

Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach.


ABSTRACT: Induced pluripotent stem cells (iPSCs) with potential for therapeutic applications can be derived from somatic cells via ectopic expression of a set of limited and defined transcription factors. However, due to risks of random integration of the reprogramming transgenes into the host genome, the low efficiency of the process, and the potential risk of virally induced tumorigenicity, alternative methods have been developed to generate pluripotent cells using nonintegrating systems, albeit with limited success. Here, we show that c-KIT+ human first-trimester amniotic fluid stem cells (AFSCs) can be fully reprogrammed to pluripotency without ectopic factors, by culture on Matrigel in human embryonic stem cell (hESC) medium supplemented with the histone deacetylase inhibitor (HDACi) valproic a

SUBMITTER: Moschidou D 

PROVIDER: S-EPMC3464631 | biostudies-literature | 2012 Oct

REPOSITORIES: biostudies-literature